An interventional study of rTMS, "repetitive transcranial magnetic stimulation" and rTMS in Schizophrenia, sponsored by Heinrich-Heine University, Duesseldorf. Completed at 1 site in Germany. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2008-01-30.
Sponsored by Heinrich-Heine University, Duesseldorf · Not applicable, Interventional, and Treatment
The study is a prospective, randomized, double-blind sham-controlled study.
The principal objective of this trial is to investigate the effect of left prefrontal high frequency rTMS on negative symptoms in schizophrenia.
3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.
This study's enrollment of 40 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →Heinrich-Heine University, Duesseldorf is the lead sponsor of 174 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
sham coil system versus verum rTMS stimulation
Procedure: rTMS, "repetitive transcranial magnetic stimulation" · Other: rTMS
10 Hz rTMS (10.000 stimuli) over left dorsolateral prefrontal cortex
repetitive transcranial magnetic stimulation, 10 Hz, 10.000 stimuli, 2 weeks
Clinical Global Impression;
Time frame: November 2007
Global psychosocial functioning (GAF), PANSS-Negative Subscale,changes in EEG, heart rate variability, cortisol daytime profile, catecholamines, cognitive functioning
Time frame: November 2007
This study is completed, as verified in Jan 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Heinrich-Heine University, Duesseldorf